Airdrop Army

Binance Labs, Binance’s VC leviathan with a $10B stash, has thrown down on BIO Protocol, aiming to tear up how biotech gets bankrolled. This isn’t just another lab coat shuffle—it’s DeSci, decentralized science, pushing the dial on biotech via onchain wizardry.

BIO Protocol ain’t shy about its ambition, with Binance Labs dubbing it a “Y Combinator for onchain Science.” No fat stacks revealed on the investment itself, but the whispers in DeFi alleys say this one’s gonna shake up the petri dish.

BIO Genesis: Tokens Meet Test Tubes in Fundraising 2.0

BIO Protocol launched BIO Genesis earlier this year, netting $6M from names like 1kx, Boost VC, and biotech titan Northpond Ventures. That first raise got heads nodding, but the second auction round wraps on November 14, bringing Zee Prime Capital, Kosmos Ventures, and Panga Capital to the table—tallying the pot at $13M+ so far.

This isn’t your trad tech crowdfund. BIO Protocol’s whole setup lets scientists, patients, and investors come in on the ground floor—co-owners and collaborators, all in on decentralized BioDAOs. It’s a slap in the face to Big Pharma’s monopoly, targeting underfunded fields like rare diseases and life extension. They’re moving drugs to DAO funding—busting the old playbook wide open.

BioDAOs: Cryo Cures, Psychedelics, and Quantum Wizardry

BIO’s BioDAOs go hard on niche tech: cryopreservation research, women’s health, and psychedelics are already in the works. Quantum microscopes, long COVID, and rare disease DAOs are next on the launchpad. So far, it’s all running on Ethereum, but plans are locked to push onto Solana and other chains in early 2025.

Decentralized AI Agents Power Up Research 24/7

This ain’t all blockchain hype—BIO’s got AI agents roped in, working round the clock in BioDAOs, autonomously driving research across the DAO ecosystem. These agents run labs without sleep, optimizing research like a cold-blooded quant. Binance Labs’ checkbook means more seed capital is inbound for fresh BioDAOs, plus support for tokenomics tweaks as BIO looks to scale.

Binance Labs, already spending big on DeFi and biotech, shows no sign of slowing. This DeSci push via BIO Protocol? A whole new fusion, putting biotech, AI, and DeFi on the same unchained roadmap.